It is estimated only 2%–3% of adult cancer patients participate in clinical trials(1). Historically, women, racial/ethnic minorities, and economically-disadvantaged adults have been underrepresented in clinical trials. Factors that contribute to this disparity include the unavailability of clinical trials at treating sites, financial strains due to increased visits, social barriers (i.e., transportation and childcare), lack of knowledge (of clinical trials) among physicians, and lack of awareness among patients. (2)
Access to and participation in clinical trials ensures patients are offered cutting-edge therapies that aim to improve the prevention, diagnosis, and treatment of cancer. The BRIDGE program facilitates world-class care to residents of Brooklyn and Queens who are faced with a blood cancer diagnosis by mitigating barriers that may prevent them from enrolling or staying on a clinical trial.
Financial Support
The program provides financial support to offset excess costs for participating in clinical trials.
Patient Navigation
Patient navigators are specifically trained to assist patients with their treatment decisions, as well as educating patients on the benefits of clinical trials as a critical treatment option.
Decision Navigation Intervention
A decision aid administered by our patient navigators that empowers cancer patients to prepare for and actively participate in medical consultations and treatment decision appointments after a positive biopsy or laboratory study confirming a cancer diagnosis
If you are interested in learning more about clinical trials open at Weill Cornell Medicine or Brooklyn Methodist Hospital, please reach out to June Greenberg, RN at (212) 746-2651 or jdg2002@med.cornell.edu.